GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Cash per Share

Microbix Biosystems (TSX:MBX) Cash per Share : C$0.10 (As of Dec. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Microbix Biosystems's Cash per Share for the quarter that ended in Dec. 2024 was C$0.10.


Microbix Biosystems Cash per Share Historical Data

The historical data trend for Microbix Biosystems's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Cash per Share Chart

Microbix Biosystems Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.08 0.10 0.09 0.10

Microbix Biosystems Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 0.09 0.10 0.10

Microbix Biosystems Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Microbix Biosystems's Cash per Share for the fiscal year that ended in Sep. 2024 is calculated as:

Microbix Biosystems's Cash per Share for the quarter that ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbix Biosystems  (TSX:MBX) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Microbix Biosystems Cash per Share Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
Executives
James Stuart Currie Senior Officer
Mark Adrian Luscher Senior Officer
Bo Hollas Director
Jennifer Anne Stewart Director
Cameron Lionel Groome Director, Senior Officer
Kenneth Hughes Senior Officer
Martin Marino Director
Peter Martin Blecher Director
Philip Jonathan Casselli Senior Officer
Steven Trevor Hagerman Senior Officer
Damian Klimaszewski Senior Officer
Anthony J. Giovinazzo Director